NDC11 63323075101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0751-01 | 63323-0751 |
| 63323-0751-1 | 63323-0751 |
| 63323-751-01 | 63323-751 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 1e77b9c8-fa17-4aa4-adc8-ff716ab2e5d7 | 2025-05-15 | Warnings, Adverse reactions | 63323-751-01 63323-751 63323075101 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | f2dce7f1-6538-4747-9792-665eee45c0a9 | 2023-12-11 | Warnings, Adverse reactions | 63323-751 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c7026b15-1228-4acb-beed-4474fcdbb972 | 2022-10-11 | Warnings, Adverse reactions | 63323-751 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.